Gene editing of pigs to control influenza A virus infections

Taeyong Kwon,Bianca L. Artiaga,Chester D. McDowell,Kristin M. Whitworth,Kevin D. Wells,Randall S. Prather,Gustavo Delhon,Mark Cigan,Stephen N. White,Jamie Retallick,Natasha N. Gaudreault,Igor Morozov,Juergen A. Richt
DOI: https://doi.org/10.1080/22221751.2024.2387449
2024-08-27
Emerging Microbes & Infections
Abstract:Proteolytic activation of the haemagglutinin (HA) glycoprotein by host cellular proteases is pivotal for influenza A virus (IAV) infectivity. Highly pathogenic avian influenza viruses possess the multibasic cleavage site of the HA which is cleaved by ubiquitous proteases, such as furin; in contrast, the monobasic HA motif is recognized and activated by trypsin-like proteases, such as the transmembrane serine protease 2 (TMPRSS2). Here, we aimed to determine the effects of TMPRSS2 on the replication of pandemic H1N1 and H3N2 subtype IAVs in the natural host, the pig. The use of the CRISPR/Cas 9 system led to the establishment of homozygous gene edited (GE) TMPRSS2 knockout (KO) pigs. Delayed IAV replication was demonstrated in primary respiratory cells of KO pigs in vitro . IAV infection in vivo resulted in a significant reduction of virus shedding in the upper respiratory tract, and lower virus titers and pathological lesions in the lower respiratory tract of TMPRSS2 KO pigs as compared to wild-type pigs. Our findings support the commercial use of GE pigs to mitigate influenza A virus infection in pigs, as an alternative approach to prevent zoonotic influenza A transmissions from pigs to humans.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?